Danish Aerospace & Defence Company A/S issues Interim report for 2026
COMPANY ANNOUNCEMENT
Odense, August 24th, 2026
Company Announcement no. 90 - 24-08-2026
Danish Aerospace & Defence Company A/S issues Interim report for 2026
The Board of Directors of Danish Aerospace and Defence Company A/S (DADC) have today approved the interim report for 2026. The report has not been audited.
Highlights - Interim Report 2026
- Revenue was DKK 8.2 million, while Gross Profit was DKK 5.7 million.
- Operating Profit (EBITDA) was DKK -2.0 million, a decrease compared to the same period last year, when EBITDA was DKK 423K.
- Net profit was DKK -2.3 million compared to DKK -570K last year.
- In April 2026, DADC completed a rights issue and raised gross proceeds of DKK 24.7 million, where 81.99% of the New Shares was subscribed through the exercise of Pre-emptive Rights and through New Shares not subscribed for by exercise of Pre-emptive Rights.
- The E4D PFM (First flight model) comprising 294 kg DADC hardware is now installed and operational in the Columbus module. As of today, E4D has been used regularly, since released for exercises, for various combinations of powered and unpowered exercises with cycling, rowing, rope pulling and resistive exercise. It has accumulated 31 hours run time. (10 in unpowered mode).
- DADC signed a contract change notice with the European Space Agency ESA, to develop and build a Motion Capture (MoCap) system for its E4D exercise equipment which will be launched and tested on the International Space Station. This system holds potential both for Human missions to the Moon and Mars, as well as for ground defense application including recovery training for injured combat personnel.
- DADC has delivered the first two models of its multifunction exercise device, E4D, under a contract with a commercial customer.
- DADC is continuing the close dialogue with multiple commercial US and European human spaceflight and defence customers concerning partnership opportunities and delivery of equipment.
- The dynamic situation in global civil spaceflight right now has affected our market in the short term. As a result, a number of expected orders has not yet materialized. As a consequence, DADC today changes its guidance for 2026. Nevertheless, in the longer term DADC remains well positioned to provide our key exercise- and medical monitoring equipment for future human space- and defence programs and other extreme environments customers.
- Guidance for the fiscal year 2026:
- Total Revenue (incl. other income) of DKK 18-20 million; and
- Operating profit (EBITDA) of approx. DKK -2 to 0 million.
CEO, Thomas A. E. Andersen, states:
“We are extremely pleased to see our E4D hardware now in operation on the International Space Station. E4D is now being used regularly, and we are gaining a lot of experience and receiving extremely valuable feedback from the crew members exercising on it.
Now we are developing the latest addition to E4D, the MoCap system, which also holds potential for defense applications, which is in line with our strategy of pursuing development of dual-use applications where possible”.
Interim Report - Danish Aerospace & Defence Company
Online presentation of key items from the Interim Report 2026 will be held on August 25th at 09:45. Join the event using the following link: DADC Interim Report 2026 online event
Attachments:
Appendix 1 – Key Figures – Interim 2026
Appendix 2 – Changes in Equity 2026
Appendix 3 – Cash Flow 2026
Note: This is a translation of the corresponding Company Announcement in Danish. In case of discrepancies between the Danish wording and the English translation, the Danish wording prevails.
For further information, please contact:
Danish Aerospace and Defence Company A/S:
CEO Thomas A.E. Andersen
Cell: +45 40 29 41 62
Certified Adviser:
ca@hcandersencapital.dk
Mobil: 30 93 18 87
Bredgade 23B, 2. 1260 København K
About Danish Aerospace and Defence Company A/S:
Danish Aerospace and Defence Company (DADC) is a high-tech company operating in the area of advanced medical instrumentation and other engineering fields primarily within space applications.
Our products are based on many years of specialized research and development. These consist of developing, integrating, and applying new as well as established medical technologies to the challenges of functioning and remaining reliable in space. These products and services bring the potential of space research and experience from space operations down to Earth for the benefit of all mankind.
Danish Aerospace and Defence Company employ engineers and technicians who deliver full engineering, production and technical services for our customers. We specialize in customer specific design, development, manufacturing, certification, maintenance, testing, and operations.
The company has developed five generations of respiratory equipment for spaceflight, ergometers for astronauts, countermeasures, adapted several commercial medical equipment for spaceflight and has participated in the development of the minus eighty-degree Celsius freezers.
The Company’s quality system is certified in obligation to BS EN ISO 9001:2015, BS EN 9100:2018 technical equivalent to AS9100D that is the acknowledged standard in the area.
Note: This is a translation of the corresponding Company Announcement in Danish. In case of discrepancies between the Danish wording and the English translation, the Danish wording prevails.
Appendix 1 - Key figures - Interim 2026
|
1/1-2026 - 30/6-2026 |
1/1-2025 - 30/6-2025 |
|
| Revenue | 8,226,451 | 9,775,062 |
| Gross profit/loss | 5,747,493 | 7,888,413 |
| Other Operating Income | 69,183 | 284,451 |
| EBITDA | -1,999,752 | 423,193 |
| Operating profit/loss | -2,208,662 | 195,785 |
| Net financials | -735,903 | -938,075 |
| Net Profit/loss for the period | -2,324,136 | -570,308 |
| Total assets | 29,308,024 | 28,158,676 |
| Equity | 22,919,273 | 7,801,083 |
|
Share performance Earnings per share (DKK) Total number of shares No. of shares (on average) Closing share price (DKK) |
-0,12 19,220,026 15,082,814 4,37 |
-0.05 10,982,872 10,945,601 8.4 |
Appendix 2 - Changes in Equity Interim 2026
| Share capital | Share premium | Reserve for development costs | Retained earnings | Total | |||||
| DKK | DKK | DKK | DKK | DKK | |||||
| Equity at 1 January | 1,098,287 | 0 | 8,026,003 | -4,411,531 | 4,712,759 | ||||
| Capital increase | 823,715 | 23,887,747 | 0 | 0 | 24,711,462 | ||||
| Costs related to the share issue | 0 | 0 | 0 | -4,180,812 | -4,180,812 | ||||
| Development costs for the period | 0 | 0 | 839,611 | -839,611 | 0 | ||||
| Depreciation, amortisation and impairment for the period | 0 | 0 | -29,154 | 29,154 | 0 | ||||
| Transfer from share premium | 0 | 23,887,747 | 0 | 23,887,747 | 0 | ||||
| Net profit/loss for the period | 0 | 0 | 0 | -2,324,136 | -2,324,136 | ||||
| Equity at 30 June | 1,922,002 | 0 | 8,836,460 | 12,160,811 | 22,919,273 |
Appendix 3 - Cash flow Interim 2026
| 1/1-2026 - | 1/1-2025 - | |||
| 6/30-2026 | 6/30-2025 | |||
| DKK | DKK | |||
| Net profit/loss for the period | -2,324,136 | -570,308 | ||
| Adjustments | 115,474 | 994,905 | ||
| Change in working capital | -4,254,131 | -386,356 | ||
| Cash flows from operating activities before financial income and expenses | -6,462,793 | 38,241 | ||
| Financial income | 7,220 | 97,813 | ||
| Financial expenses | -743,623 | -1,035,888 | ||
| Cash flows from operating activities | -7,199,196 | -889,834 | ||
| Purchase of intangible assets | -1,134,429 | -894,095 | ||
| Purchase of property, plant and equipment | -85,283 | -36,635 | ||
| Cash flows from investing activities | -1,219,712 | -930,730 | ||
| Raising of loans from credit institutions | -12,299,328 | -300,822 | ||
| Loans to group enterprises | 0 | 55,592 | ||
| Change in loans from owners and Management | 0 | 1,500,000 | ||
| Capital increase | 20,530,650 | 478,561 | ||
| Cash flows from financing activities | 8,231,322 | 1,733,331 | ||
| Change in cash and cash equivalents | -187,586 | -97,233 | ||
| Cash and cash equivalents at 1 January | 200,143 | 297,379 | ||
| Cash and cash equivalents at 30 June | 12,557 | 200,143 | ||